1887

oa South African Journal of Clinical Nutrition - Acceptance of a ready-to-use supplementary food by stable HIV-treated and HIV and tuberculosis (co-infected)-treated patients : original research

 

Abstract

The objective of the study was to determine consumer acceptance and perceptions of a ready-to-use supplementary food (RUSF) by subjects treated for human immunodeficiency virus (HIV) and HIV and tuberculosis (co-infected subjects).


A cross-sectional study was conducted.
One hundred and thirty-nine stable HIV-treated and HIV and tuberculosis (co-infected)-treated patients participated in the study. Sixty-eight healthy subjects served as the control group.
The setting was Northdale Hospital and Grey's Hospital in Pietermaritzburg, KwaZulu-Natal.
Acceptance of the RUSF was assessed using a five-point facial hedonic scale by stable HIV-treated and HIV and tuberculosis (co-infected)-treated patients (n = 139) from Northdale Hospital and Grey's Hospital in Pietermaritzburg, KwaZulu-Natal. Perceptions of the RUSF were determined through focus group discussions in which HIV-treated and HIV and tuberculosis (co-infected)-treated patients (n = 43) participated.
The overall acceptance of the RUSF was significantly associated with the health status of the subjects (p-value < 0.05). Overall, the product was liked by more than 90% of the HIV-treated and HIV and tuberculosis (co-infected)-treated individuals compared to 85% of the control group. More than 90% of the HIV-treated and HIV and tuberculosis (co-infected)-treated individuals liked the taste, compared to 87% of the control group. The colour and mouth feel were rated to be "good" by more than 80% of the HIV-treated and HIV and tuberculosis (co-infected)-treated group, compared to approximately 70% of the healthy group. Focus group discussions revealed that the subjects perceived the mouth feel of the RUSF to be "rough", and that as a health supplement, the RUSF should be provided free of charge, or at a reasonable cost, at public health centres.
The RUSF was found to be highly acceptable to stable HIV-treated and HIV and tuberculosis (co-infected)-treated subjects, although concern was raised about the mouth feel.

Loading

Article metrics loading...

/content/m_sajcn/27/1/EJC152941
2014-01-01
2016-12-06
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error